MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma

Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials